These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17680034)

  • 61. Carbonyl-substituted titanocenes: a novel class of cytostatic compounds with high antitumor and antileukemic activity.
    Gansäuer A; Winkler I; Worgull D; Lauterbach T; Franke D; Selig A; Wagner L; Prokop A
    Chemistry; 2008; 14(14):4160-3. PubMed ID: 18384037
    [No Abstract]   [Full Text] [Related]  

  • 62. The blood-testis barrier as a target of some chemotherapeutic agents.
    Pereira ML; Garcia e Costa F
    Chemotherapy; 2007; 53(6):446-8. PubMed ID: 17957098
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The hydrolysis mechanism of the anticancer ruthenium drugs NAMI-A and ICR investigated by DFT-PCM calculations.
    Vargiu AV; Robertazzi A; Magistrato A; Ruggerone P; Carloni P
    J Phys Chem B; 2008 Apr; 112(14):4401-9. PubMed ID: 18348562
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
    Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
    Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis, molecular structure (X-ray and DFT), and solution behavior of titanium 4-Acyl-5-pyrazolonates. Correlations with related antitumor beta-diketonato derivatives.
    Caruso F; Pettinari C; Marchetti F; Natanti P; Phillips C; Tanski J; Rossi M
    Inorg Chem; 2007 Sep; 46(18):7553-60. PubMed ID: 17691769
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Electron-spectroscopic imaging--a method for analysing the distribution of light elements in mammalian cells and tissues.
    Köpf-Maier P
    Acta Histochem; 1991; 91(1):25-37. PubMed ID: 1801512
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anticancer activity and mode of action of titanocene C.
    Olszewski U; Claffey J; Hogan M; Tacke M; Zeillinger R; Bednarski PJ; Hamilton G
    Invest New Drugs; 2011 Aug; 29(4):607-14. PubMed ID: 20162321
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Markedly different cytotoxicity of the two enantiomers of C(2)-symmetrical Ti(IV) phenolato complexes; mechanistic implications.
    Manna CM; Tshuva EY
    Dalton Trans; 2010 Feb; 39(5):1182-4. PubMed ID: 20104339
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents.
    Wang X; Guo Z
    Dalton Trans; 2008 Mar; (12):1521-32. PubMed ID: 18335133
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Highly enantioselective vinyl additions of vinylaluminum to ketones catalyzed by a titanium(IV) catalyst of (S)-BINOL.
    Biradar DB; Gau HM
    Org Lett; 2009 Feb; 11(3):499-502. PubMed ID: 19117491
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Anti-tumoral Titanium
    Zhao T; Wang P; Zhang X; Liu N; Zhao W; Zhang Y; Yuan P; Li S; Yang M; Yang Z; Huhn T
    Curr Top Med Chem; 2023; 23(19):1835-1849. PubMed ID: 37151173
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A controlled release system of titanocene dichloride by electrospun fiber and its antitumor activity in vitro.
    Chen P; Wu QS; Ding YP; Chu M; Huang ZM; Hu W
    Eur J Pharm Biopharm; 2010 Nov; 76(3):413-20. PubMed ID: 20854905
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A categorization of metal anticancer compounds based on their mode of action.
    Gianferrara T; Bratsos I; Alessio E
    Dalton Trans; 2009 Oct; (37):7588-98. PubMed ID: 19759927
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
    van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ
    J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A proposed mechanism for the inhibitory effect of the anticancer agent titanocene dichloride on tumour gelatinases and other proteolytic enzymes.
    Pavlaki M; Debeli K; Triantaphyllidou IE; Klouras N; Giannopoulou E; Aletras AJ
    J Biol Inorg Chem; 2009 Aug; 14(6):947-57. PubMed ID: 19390879
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Guanine binding to dirhodium tetracarboxylate anticancer complexes: quantum chemical calculations unravel an elusive mechanism.
    Deubel DV; Chifotides HT
    Chem Commun (Camb); 2007 Sep; (33):3438-40. PubMed ID: 17700874
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Combining Fourier transform nuclear quadrupole resonance (FT-NQR) spectroscopy and mass spectrometry (MS) to study the electronic structure of titanocene dichlorides.
    Kubišta J; Civiš M; Spaněl P; Civiš S
    Analyst; 2012 Mar; 137(6):1338-42. PubMed ID: 22318905
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles.
    Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N
    J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Titanium complexes in cancer treatment.
    Meléndez E
    Crit Rev Oncol Hematol; 2002 Jun; 42(3):309-15. PubMed ID: 12050022
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis and structure-activity relationship study of organometallic bioconjugates of the cyclic octapeptide octreotate.
    Gross A; Habig D; Metzler-Nolte N
    Chembiochem; 2013 Dec; 14(18):2472-9. PubMed ID: 24218362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.